search
Back to results

Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards

Primary Purpose

Diabetes Mellitus Type 2

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Insulin, regular - act rapid
Insulin glulisine, Insulin glargine
Sponsored by
HaEmek Medical Center, Israel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus Type 2

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients admitted to internal medicine ward with blood glucose (BG) between 140-400 mg/dl.
  • Known history (>6months) of diabetes.
  • Aged 18-80 years old.
  • Previous therapy including either diet alone or any combination of oral hypoglycemia agents, glucagon-like peptide 1 (GLP-1) analogs and long acting insulin analogs or Neutral Protamine Hagedorn (NPH).

Exclusion Criteria:

  • Pregnancy
  • Patients with ketoacidosis
  • Patients with unknown history of diabetes
  • Patients with type 1 diabetes mellitus
  • Patients with clinically relevant hepatic disease or renal impairment ( serum creatinine≥2.5 mg/dl)
  • Use of corticosteroid therapy
  • Patient with any mental disorder preventing him to cooperate and give informed consent.
  • Patients on multiple daily doses of insulin regimen.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    sliding scale

    basal bolus

    Arm Description

    Outcomes

    Primary Outcome Measures

    Secondary Outcome Measures

    Full Information

    First Posted
    May 7, 2012
    Last Updated
    February 27, 2018
    Sponsor
    HaEmek Medical Center, Israel
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01594060
    Brief Title
    Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards
    Official Title
    A Randomized, Comparative Study of Basal-bolus Insulin Versus Conventional Sliding-scale Regular Insulin Therapy in Management of Non-critically Ill Patients Hospitalized in the Medical Ward.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    June 2012 (undefined)
    Primary Completion Date
    October 2014 (Actual)
    Study Completion Date
    October 2014 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    HaEmek Medical Center, Israel

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    A comparison of two treatment approaches for hyperglycemia in diabetic patients hospitalized in the medical department. The first approach is called basal-bolus in which 4 insulin shots are given daily ( 3 short acting before meals and one long acting before bed time). The second approach is called sliding scale in which short acting insulin alone is given before meals and before bed time according to the patient's glucose values. The aim is to keep fasting glucose between 140-180 mg/dl.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Diabetes Mellitus Type 2

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    36 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    sliding scale
    Arm Type
    Active Comparator
    Arm Title
    basal bolus
    Arm Type
    Active Comparator
    Intervention Type
    Drug
    Intervention Name(s)
    Insulin, regular - act rapid
    Intervention Description
    4 shots of regular insulin: 3 before meals and one at bedtime.
    Intervention Type
    Drug
    Intervention Name(s)
    Insulin glulisine, Insulin glargine
    Intervention Description
    1 shot glargine at bedtime 3 shots glulisine before meals

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    100 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients admitted to internal medicine ward with blood glucose (BG) between 140-400 mg/dl. Known history (>6months) of diabetes. Aged 18-80 years old. Previous therapy including either diet alone or any combination of oral hypoglycemia agents, glucagon-like peptide 1 (GLP-1) analogs and long acting insulin analogs or Neutral Protamine Hagedorn (NPH). Exclusion Criteria: Pregnancy Patients with ketoacidosis Patients with unknown history of diabetes Patients with type 1 diabetes mellitus Patients with clinically relevant hepatic disease or renal impairment ( serum creatinine≥2.5 mg/dl) Use of corticosteroid therapy Patient with any mental disorder preventing him to cooperate and give informed consent. Patients on multiple daily doses of insulin regimen.

    12. IPD Sharing Statement

    Learn more about this trial

    Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards

    We'll reach out to this number within 24 hrs